Find policies, billing codes, payers, states, and providers
CPT 87590: Neisseria gonorrhoeae Direct Nucleic Acid Probe Test
CPT code 87590 denotes a laboratory molecular diagnostic procedure using a direct nucleic acid probe to detect Neisseria gonorrhoeae. This test is clinically significant for diagnosing gonococcal infection and guiding appropriate public health and treatment actions. Nationally, accurate and timely detection of Neisseria gonorrhoeae supports sexually transmitted infection control efforts and impacts outpatient and laboratory service utilization.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical context, typical sites of service, and common billing modifiers. The publication summarizes available benchmarks and reimbursement context where provided, highlights coding and billing considerations for laboratory and hospital laboratories, and outlines areas where policy updates or payer-specific rules can affect coverage and claims processing. The content is aimed at billing managers, laboratory directors, and revenue cycle professionals seeking a concise reference for CPT code 87590.
Customize your policy alerts
Sign up for cpt 87590 policy alerts
Get alerted when payer policies referencing 87590 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 87590 describes a laboratory test in which a lab analyst performs a direct nucleic acid probe technique to detect Neisseria gonorrhoeae, the bacterium that causes gonorrhea. This service is a molecular diagnostic test that identifies bacterial nucleic acid directly from patient specimens.
-
Service type: Molecular diagnostic testing using direct nucleic acid probe technique
-
Typical site of service: Clinical laboratory or hospital laboratory performing diagnostic microbiology testing
Data not available in the input.